Wound care matrices for chronic leg ulcers: role in therapy

References

• Kahle B, Hermanns HJ, Gallenkemper G. Evidence-based treatment of chronic leg ulcers. Dtsch Arztebl Int. 2011;108(14):231–237.
   Web of Science ®Google Scholar
• Hodde JP, Johnson CE. Extracellular matrix as a strategy for treating chronic wounds. Am J Clin Dermatol. 2007;8(2):61–66.
   Web of Science ®Google Scholar
• Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol. 1994;130(4):489–493.
   PubMed Web of Science ®Google Scholar
• Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11:1s–23s.
   Web of Science ®Google Scholar
• Sibbald RG, Williamson D, Orsted HL. Preparing the wound bed: debridement, bacterial balance, and moisture balance. Ostomy Wound Manage. 2000;46:14–35.
   PubMedGoogle Scholar
• Hopf HW, Ueno C, Aslam R, et al. Guidelines for the treatment of arterial insufficiency ulcers. Wound Repair Regen. 2006;14(6):693–710.
   PubMed Web of Science ®Google Scholar
• Steed DL. Debridement. Am J Surg. 2004;187(Suppl 5A):71s–74s.
   Web of Science ®Google Scholar
• Sieggreen MY, Maklebust J. Debridement: choices and challenges. Adv Wound Care. 1997;10:32–37.
   Google Scholar
• Bradley M, Cullum N, Sheldon T. The debridement of chronic wounds: a systematic review. Health Technol Assess. 1999;3(17 pt 1):1–78.
   Google Scholar
• Mosher BA, Cuddigan J, Thomas DR, et al. Outcomes of 4 methods of debridement using a decision analysis methodology. Adv Wound Care. 1999;12:81–88.
   Google Scholar
• Davies CE, Turton G, Woolfrey G, Elley R, Taylor M. Exploring debridement options for chronic venous leg ulcers. Br J Nurs. 2005;14:393–397.
   Google Scholar
• Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg. 1996;183:61–64.
   PubMed Web of Science ®Google Scholar
• Ayello EA, Cuddigan J. Debridement: controlling the necrotic/cellular burden. Adv Skin Wound Care. 2004;17:66–75.
   PubMedGoogle Scholar
• Schmeller W, Gaber Y, Gehl HB. Shave therapy is a simple, effective treatment of persistent venous leg ulcers. J Am Acad Dermatol. 1998;39:232–238.
   Web of Science ®Google Scholar
• Bouza C, Munoz A, Amate JM. Efficacy of modern dressings in the treatment of leg ulcers: a systematic review. Wound Repair Regen. 2005;13:218–229.
   PubMed Web of Science ®Google Scholar
• Sheridan RL, Hegarty M, Tompkins RG, Burke JF. Artificial skin in massive burns – results to ten years. Eur J Plastic Surg. 1994;17:91–93.
   Google Scholar
• Metcalfe AD, Ferguson MW. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface. 2007;4(14):413–437.
   PubMed Web of Science ®Google Scholar
• Bello YM, Falabella AF, Eaglstein WH. Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol. 2001;2(5):305–313.
   PubMedGoogle Scholar
• Papanas N, Eleftheriadou I, Tentolouris N, Maltezos E. Advances in the topical treatment of diabetic foot ulcers. Curr Diabetes Rev. 2012; 8(3):209–218.
   PubMedGoogle Scholar
• Linsenmayer TF. Collagen. In: Hay ED, editor. Cell Biology of Extracellular Matrix. New York: Plenum Press; 1985:5–37.
   Google Scholar
• Chvapil M, Kronenthal RL, Winkle WV Jr. Medical and surgical applications of collagen. In: Hall DA, Jackson DS, editors. International Review of Connective Tissue Research. Vol 6. New York: Academic Press; 1973:1–61. [ISBN 9780123637109].
   Google Scholar
• Doillon CJ, Silver FH. Collagen-based wound dressing: effects of hyaluronic acid and fibronectin on wound healing. Biomaterials. 1986;7:3–8.
   PubMed Web of Science ®Google Scholar
• Yannas IV, Burke JF. Design of an artificial skin I. Basic design principles. J Biomed Mater Res. 1980;14:65–81.
   PubMed Web of Science ®Google Scholar
• Leipziger LS, Glushko V, DiBernardo B, et al. Dermal wound repair: role of collagen matrix implants and synthetic polymer dressing. J Am Acad Dermatol. 1985;12:409–419.
   PubMed Web of Science ®Google Scholar
• Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. A living tissue formed in vitro and accepted as a full thickness skin equivalent. Science. 1981;211:1042–1054.
   Web of Science ®Google Scholar
• Braden BJ, Bergstrom N. Clinical utility of the Braden scale for predicting pressure sore risk. Decubitus. 1989;2(44–46):50–51.
   Google Scholar
• Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg. 2001;54:659–664.
   PubMedGoogle Scholar
• Hill JL, Wong L, Kemper P, Buseman J, Davenport DL, Vasconez HC. Infectious complications associated with the use of acellular dermal matrix in implant-based bilateral breast reconstruction. Ann Plast Surg. 2012;68(5):432–434.
   Web of Science ®Google Scholar
• Ono I, Zhou LJ, Tateshita T. Effects of a collagen matrix containing prostaglandin E(1) on wound contraction. J Dermatol Sci. 1999;48(5):106–115.
   Google Scholar
• Ono I, Tateshita T, Inoue M. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction. J Biomed Mater Res. 1998;6(3):621–630.
   Google Scholar
• Tateshita T, Ono I, Kaneko F. Effects of collagen matrix containing transforming growth factor (TGF)-beta(1) on wound contraction. J Dermatol Sci. 2001;25(2):104–113.
   Web of Science ®Google Scholar
• Inoue M, Ono I, Tateshita T, Kuroyanagi Y, Shioya N. Effect of a collagen matrix containing epidermal growth factor on wound contraction. Wound Repair Regen. 1998;6(3):213–222.
   Google Scholar
• Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol. 2003;139:510–516.
   PubMed Web of Science ®Google Scholar
• Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC. CD34_ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res. 2003;40:368–377.
   PubMed Web of Science ®Google Scholar
• McFarlin K, Gao X, Liu YB, et al. Bone marrow derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen. 2006;14:471–478.
   PubMed Web of Science ®Google Scholar
• Borue X, Lee S, Grove J, et al. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol. 2004;165:1767–1772.
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–387.
   PubMed Web of Science ®Google Scholar
• Driver VR, Hanft J, Fylling CP, Beriou JM; Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52(6):68–70, 72, 74 assim.
   PubMed Web of Science ®Google Scholar
• Giano C, Tenewitz FE, Wilson RC, Moyles BG. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J. Foot Ankle Surg. 1993;32:263–268.
   Google Scholar
• Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet. 1990;170:56–60.
   PubMedGoogle Scholar
• Minamimura A, Ichioka S, Sano H, Sekiya N. Comparison of collagen matrix treatment impregnated with platelet rich plasma vs bone marrow. J Plast Surg Hand Surg. 2014;48(1):15–20.
   PubMed Web of Science ®Google Scholar
• Minamimura A, Ichioka S, Sano H, Shoichi Ishikawa S. Treatment of non-healing limb ulcers with platelet-rich plasma. JPRAS. 2013;33(5):304–309.
   Google Scholar
• Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69:513–521.
   PubMed Web of Science ®Google Scholar
• Krause DS, Theise ND, Collector MI, et al. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369–377.
   PubMed Web of Science ®Google Scholar
• Liang L, Bickenbach JR. Somatic epidermal stem cells can produce multiple cell lineages during development. Stem Cells. 2002;20:21–31.
   PubMed Web of Science ®Google Scholar
• Ichioka S, Kouraba S, Sekiya N, Ohura N, Nakatsuka T. Bone marrow- impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg. 2005;58(8):1124–1130.
   PubMedGoogle Scholar
• Ichioka S, Yokogawa H, Sekiya N, et al. Determinants of wound healing in bone marrow-impregnated collagen matrix treatment: impact of microcirculatory response to surgical debridement. T Wound Repair Regen. 2009;17(4):492–497.
   Web of Science ®Google Scholar
• Sano H, Ichioka S, Kouraba S, et al. Treatment of venous ulcers with bone marrow-impregnated collagen matrix. J Plast Surg Hand Surg. 2012;46(1):37–44.
   Web of Science ®Google Scholar
• Mizuno H, Miyamoto M, Shimamoto M, Koike S, Hyakusoku H, Kuroyanagi Y. Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia. J Plast Reconstr Aesthet Surg. 2010;63(11):1875–1882.
   Web of Science ®Google Scholar
• Everts PA, Brown Mahoney C, Hoffmann JJ, et al. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors. 2006;24(3):165–171.
   PubMed Web of Science ®Google Scholar
• Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;204(3):322–330.
   PubMed Web of Science ®Google Scholar
• Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, Austin L. The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res. 1988;266:319–329.
   PubMedGoogle Scholar
• Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003;90:133–146.
   PubMed Web of Science ®Google Scholar
• Assoian RK, Sporn MB. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol. 1986;102:1217–1223.
   PubMed Web of Science ®Google Scholar
• Hock JM, Gentrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology. 1988;122:254–260.
   PubMed Web of Science ®Google Scholar
• Möhle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A. 1997;94:663–668.
   PubMed Web of Science ®Google Scholar
• Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood. 1993;81:631–638.
   PubMed Web of Science ®Google Scholar
• Mehta S, Watson JT. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma. 2008;22(6):432–438.
   PubMed Web of Science ®Google Scholar
• Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–228.
   PubMedGoogle Scholar
• Shashikiran ND, Reddy VV, Yavagal CM, Zakirulla M. Applications of platelet-rich plasma (PRP) in contemporary pediatric dentistry. J Clin Pediatr Dent. 2006;30(4):283–286.
   Google Scholar
• Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002;18(1):27–33.
   PubMedGoogle Scholar
• Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-beta (TGFbeta). Growth Factors. 1993;8:1–9.
   PubMed Web of Science ®Google Scholar
• Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638–646.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D. Molecular and developmental biology aspects of fibroblast growth factor. Adv Exp Med Biol. 1988;234:23–39.
   Google Scholar
• Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8:95–114.
   PubMed Web of Science ®Google Scholar
• Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol. 1990;136:1235–1246.
   PubMed Web of Science ®Google Scholar
• Floss T, Arnold HH, Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 1997;11:2040–2045.
   PubMed Web of Science ®Google Scholar
• Menetrey J, Kasemkijwattana C, Day CS, et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg Br. 2000;82:131–137.
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Harada S, Takemura T, et al. Clinical effectiveness of KCB-1(bFGF) on patients with skin ulcerations clinical trial for 12 weeks. J Clin Therapeut Med. 1996;12:2117–2129.
   Google Scholar
• Ichioka S, Ohura N, Nakatsuka T. The positive experience using a growth factor product on deep wounds with bone exposure. J Wound Care. 2005;14(3):105–109.
   Google Scholar
• Wu Z, Fan L, Xu B, Lin Y, Zhang P, Wei X. Use of decellularized scaffolds combined with hyaluronic acid and basic fibroblast growth factor for skin tissue engineering. Tissue Eng Part A. 2015;21(1–2):390–402.
   PubMed Web of Science ®Google Scholar
• Li W, Lan Y, Guo R, Zhang Y, Xue W, Zhang Y. In vitro and in vivo evaluation of a novel collagen/cellulose nanocrystals scaffold for achieving the sustained release of basic fibroblast growth factor. J Biomater Appl. 2015;29(6):882–893.
   PubMed Web of Science ®Google Scholar
• Morimoto N, Yoshimura K, Niimi M, et al. Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcers. Tissue Eng Part A. 2013;19(17–18):1931–1940.
   PubMed Web of Science ®Google Scholar
• Takemoto S, Kawai K, Yokode M, Shimizu A, Suzuki S. An exploratory clinical trial for combination wound therapy with a novel medical matrix and fibroblast growth factor in patients with chronic skin ulcers: a study protocol. Am J Transl Res. 2012;4(1):52–59.
   Web of Science ®Google Scholar
• Huang C, Leavitt T, Bayer LR, Orgill DP. Effect of negative pressure wound therapy on wound healing. Curr Probl Surg. 2014;51(7):301–331.
   PubMed Web of Science ®Google Scholar
• Peinemann F, Sauerland S. Negative-pressure wound therapy: systematic review of randomized controlled trials. Dtsch Arztebl Int. 2011;108(22):381–389.
   PubMed Web of Science ®Google Scholar
• Borgquist O, Ingemansson R., Malmsjö M. Individualizing the use of negative pressure wound therapy for optimal wound healing: a focused review of the literature. Ostomy Wound Manage. 2011;57(4):44–54.
   Google Scholar
• Menn ZK, Lee E, Klebuc MJ. Acellular dermal matrix and negative pressure wound therapy: a tissue-engineered alternative to free tissue transfer in the compromised host. J Reconstr Microsurg. 2012;28(2):139–144.
   Web of Science ®Google Scholar